Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Leukemia

  Free Subscription


29.04.2019

1 Am J Hematol
4 Ann Hematol
1 Biochem Biophys Res Commun
4 Blood
1 BMC Cancer
1 Cancer
1 Exp Hematol
1 J Pediatr Hematol Oncol
6 Leuk Lymphoma
1 Leuk Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. RIBES D, El Hachem H, Oberic L, Vergez F, et al
    Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.
    Am J Hematol. 2017 Nov 23. doi: 10.1002/ajh.24984.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. GARRASTAZUL-SANCHEZ MP, Vilches-Moreno M, Fernandez-Valle MC, Marchante-Cepillo I, et al
    Neutrophil faggot cells and inv(16): not such a fortuitous association?
    Ann Hematol. 2019;98:1293-1295.
    PubMed     Text format    

  3. AMMATUNA E, Huls G
    Multidimensional radar dot-plots, do we need it for the screening of acute promyelocytic leukemia?
    Ann Hematol. 2019 Apr 25. pii: 10.1007/s00277-019-03693.
    PubMed     Text format    

  4. SHIN HJ, Min WS, Min YH, Cheong JW, et al
    Different prognostic effects of core-binding factor positive AML with Korean AML registry data.
    Ann Hematol. 2019;98:1135-1147.
    PubMed     Text format     Abstract available

  5. MASHIMA K, Ikeda T, Kawaguchi SI, Toda Y, et al
    Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia.
    Ann Hematol. 2019;98:1127-1133.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  6. ZHOU P, Chen X, Li M, Tan J, et al
    2-D08 as a SUMOylation inhibitor induced ROS accumulation mediates apoptosis of acute myeloid leukemia cells possibly through the deSUMOylation of NOX2.
    Biochem Biophys Res Commun. 2019 Apr 19. pii: S0006-291X(19)30713.
    PubMed     Text format     Abstract available


    Blood

  7. BJORKHOLM M, Edgren G, Dickman PW
    Trends in survival of young adult patients with acute lymphoblastic leukemia in Sweden and USA.
    Blood. 2019 Apr 25. pii: blood.2019001168. doi: 10.1182/blood.2019001168.
    PubMed     Text format    

  8. DERRIEUX C, Tarfi S
    Azurophilic granular blasts are not always part of myeloid lineage: an atypical case of BCP acute lymphoblastic leukemia.
    Blood. 2019;133:1919.
    PubMed     Text format    

  9. SCHEFFOLD A, Jebaraj BMC, Tausch E, Bloehdorn J, et al
    IGF1R as druggable target mediating PI3K-delta inhibitor resistance in a murine model of chronic lymphocytic leukemia.
    Blood. 2019 Apr 22. pii: blood.2018881029. doi: 10.1182/blood.2018881029.
    PubMed     Text format     Abstract available

  10. ROBERTS AW, Ma S, Kipps TJ, Coutre SE, et al
    Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables.
    Blood. 2019 Apr 25. pii: blood.2018882555. doi: 10.1182/blood.2018882555.
    PubMed     Text format     Abstract available


    BMC Cancer

  11. WANG R, Gao X, Yu L
    The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
    BMC Cancer. 2019;19:389.
    PubMed     Text format     Abstract available


    Cancer

  12. RIBERA JM, Garcia O, Moreno MJ, Barba P, et al
    Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32156.
    PubMed     Text format     Abstract available


    Exp Hematol

  13. BARBOSA K, Deshpande A, Chen BR, Ghosh A, et al
    Acute Myeloid Leukemia Driven by the CALM-AF10 Fusion Gene is Dependent on BMI1.
    Exp Hematol. 2019 Apr 22. pii: S0301-472X(19)30187.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  14. GONG ZH, Li J, Wang XY, Yu Y, et al
    A Meta-analysis of Traffic-related Air Pollution and Risk of Childhood Leukemia.
    J Pediatr Hematol Oncol. 2019;41:267-274.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  15. TALLIS E, Loghavi S, Jorgensen JL, Wang S, et al
    Patient with mixed-phenotype acute leukemia with CBFB rearrangement.
    Leuk Lymphoma. 2019 Apr 23:1-3. doi: 10.1080/10428194.2019.1605069.
    PubMed     Text format    

  16. ALDOSS I, Pullarkat V
    Response to single agent dasatinib post allogeneic transplant in B-cell acute lymphoblastic leukemia with NUP214-ABL1.
    Leuk Lymphoma. 2019 Apr 24:1-3. doi: 10.1080/10428194.2019.1605510.
    PubMed     Text format    

  17. HAMPEL PJ, Ding W, Call TG, Rabe KG, et al
    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.
    Leuk Lymphoma. 2019 Apr 24:1-8. doi: 10.1080/10428194.2019.1602268.
    PubMed     Text format     Abstract available

  18. BEZERRA ED, Flowers ME, Onstad LE, Chielens D, et al
    A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation.
    Leuk Lymphoma. 2019 Apr 24:1-8. doi: 10.1080/10428194.2019.1605508.
    PubMed     Text format     Abstract available

  19. XIE W, Chen Z, Wang SA, Hu S, et al
    Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
    Leuk Lymphoma. 2019 Apr 24:1-9. doi: 10.1080/10428194.2019.1605509.
    PubMed     Text format     Abstract available

  20. GABELLI M, Disaro S, Scarparo P, Francescato S, et al
    Cerebrospinal fluid analysis by 8-color flow cytometry in children with acute lymphoblastic leukemia.
    Leuk Lymphoma. 2019 Apr 25:1-4. doi: 10.1080/10428194.2019.1602269.
    PubMed     Text format    


    Leuk Res

  21. STEVENS B, Winters A, Gutman JA, Fullerton A, et al
    Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.
    Leuk Res. 2019;81:43-49.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: